Jul. 16 at 6:56 PM
$LEXX Big news!!! 🚨 ‼️
Novo Nordisk Receives EU Approval for Oral Wegovy
$NVO
This makes it the first oral GLP-1 approved for weight management in the European Union.
This is a definitive, regulatory declaration that the future of GLP-1 is oral. Novo Nordisk's CEO openly stated, "For many people, a tablet may be a simpler and more acceptable way to start and continue treatment."
To make oral semaglutide absorbable, Novo Nordisk relies on a massive dose of an absorption enhancer called SNAC. However, SNAC-based absorption is notoriously erratic, requiring patients to fast and take the pill with restricted water.
If Lexaria's Human Study #7 (dropping in late August) proves that DehydraTECH achieves superior absorption over standard tablets with lower doses and better tolerability, they possess the key to optimizing the very product the EU just approved.
https://www.reuters.com/legal/litigation/novo-nordisk-wins-eu-approval-wegovy-weight-loss-pill-2026-07-15/
$LLY $PFE $VKTX
